Access Capital Closes $5 Million Facility with TPS

Transformative Pharmaceutical Solutions (“TPS”) is a specialized provider of human capital and proprietary software solutions for the management and execution of clinical trials to the pharmaceutical industry.

TPS was founded in 2015 by Daniel Perlman, who has an established track record of building industry-leading companies and pioneering innovative solutions to the clinical trial practice.

So far this year, TPS is reflecting a vast increase in its sales growth and projects continued and fast-paced growth over the next few years.

As a means to provide support for the significant growth projected over the next two years, Access Capital is providing a credit facililty to TPS for $5 million.

“TPS is pleased to add Access Capital as a partner. We believe this relationship will help us continue the exceptional growth we are achieving,” said Dan Perlman, CEO Transformative Pharmaceutical Solutions.

About Access Capital: We are the nation’s foremost lender to staffing enterprises and have been serving the industry providing asset-based lending and acquisition financing for over three decades.